Wells Fargo & Company Opiant Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.38 - $20.29 $640,682 - $1.39 Million	-68,303 Reduced 33.3%	136,814 $2.77 Million
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $17,954 - $25,423	1,886 Added 0.93%	205,117 $2.21 Million
Q2 2022 Aug 12, 2022	SELL	$10.12 - $23.32 $20,189 - $46,523	-1,995 Reduced 0.97%	203,231 $2.44 Million
Q1 2022 May 16, 2022	SELL	$19.54 - $33.59 $372,647 - $640,594	-19,071 Reduced 8.5%	205,226 $4.4 Million
Q4 2021 Feb 14, 2022	SELL	$22.51 - $36.79 $522,119 - $853,344	-23,195 Reduced 9.37%	224,297 $7.54 Million
Q3 2021 Nov 15, 2021	SELL	$13.28 - $25.79 $46,679 - $90,651	-3,515 Reduced 1.4%	247,492 $6.37 Million
Q2 2021 Aug 16, 2021	BUY	$10.5 - $14.19 $9,712 - $13,125	925 Added 0.37%	251,007 $3.36 Million
Q1 2021 May 13, 2021	SELL	$8.2 - $14.49 $17,408 - $30,762	-2,123 Reduced 0.84%	250,082 $2.66 Million
Q4 2020 Feb 09, 2021	BUY	$6.87 - $8.88 $310,901 - $401,864	45,255 Added 21.87%	252,205 $2.03 Million
Q3 2020 Nov 05, 2020	BUY	$7.48 - $9.54 $713,696 - $910,249	95,414 Added 85.55%	206,950 $1.55 Million
Q2 2020 Aug 13, 2020	BUY	$8.64 - $11.87 $930,657 - $1.28 Million	107,715 Added 2819.03%	111,536 $1.01 Million
Q1 2020 May 14, 2020	BUY	$9.11 - $14.42 $34,809 - $55,098	3,821 New	3,821 $36,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.